← Leaderboards
Constantine E Frangakis
Johns Hopkins University
$7,699,648
Attributed
$7,699,648
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $865.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,699,648 · 6
By mechanism
R01$6,390,566 · 5
P01$1,309,082 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- William George Nelson$34,555,726
- Peter Cm Van Zijl$39,753,414
- Gregory D Kirk$60,349,977
- Richard E Chaisson$50,014,616
- Richard D Schulick$14,841,770
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsDesignRandomizedResearch PersonnelAids/Hiv ProblemEvaluationTreatment ProgramBaseSuccessStatistical MethodsPhysiciansResourcesAlzheimer&AposMonitorAccountingLettersSiteStratificationChildEnsureEmergency SituationAcquired Immunodeficiency SyndromeAfricaPublications
Grant awards (22)
Statistical methods to characterize patients who highly benefit across multifaceted clinical outcomes, from treatments in Alzheimers Disease and Related Dementias (ADRD)$431,386
R01 · FY2025 · AG · contact PI
Statistical methods to characterize patients who highly benefit across multifaceted clinical outcomes, from treatments in Alzheimers Disease and Related Dementias (ADRD)$471,932
R01 · FY2024 · AG · contact PI
Statistical methods for characterizing patients who highly-benefit from treatments and programs in Alzheimers, HIV, and other heterogeneous diseases$444,542
R01 · FY2021 · AI · contact PI
Statistical methods for characterizing patients who highly-benefit from treatments and programs in Alzheimers, HIV, and other heterogeneous diseases$444,542
R01 · FY2020 · AI · contact PI
Statistical methods for characterizing patients who highly-benefit from treatments and programs in Alzheimers, HIV, and other heterogeneous diseases$444,542
R01 · FY2019 · AI · contact PI
Statistical methods for characterizing patients who highly-benefit from treatments and programs in Alzheimers, HIV, and other heterogeneous diseases$492,267
R01 · FY2018 · AI · contact PI
Statistical Designs and Methods for Double-Sampling for HIV/AIDS$393,346
R01 · FY2016 · AI · contact PI
Statistical Designs and Methods for Double-Sampling for HIV/AIDS$391,088
R01 · FY2015 · AI · contact PI
Statistical Designs and Methods for Double-Sampling for HIV/AIDS$388,884
R01 · FY2014 · AI · contact PI
Statistical Designs and Methods for Double-Sampling for HIV/AIDS$408,141
R01 · FY2013 · AI · contact PI
DESIGN, RANDOMIZATION AND ANALYSIS CORE$538,867
P01 · FY2010 · AG · contact PI
Statistical Designs and Methods for Partially Controlled HIV/AIDS Studies$326,227
R01 · FY2010 · DA · contact PI
DESIGN, RANDOMIZATION AND ANALYSIS CORE$401,920
P01 · FY2009 · AG · contact PI
Statistical Designs and Methods for Partially Controlled HIV/AIDS Studies$330,550
R01 · FY2009 · DA · contact PI
Statistical Designs and Methods for Partially Controlled HIV/AIDS Studies$327,082
R01 · FY2008 · DA · contact PI
DESIGN, RANDOMIZATION AND ANALYSIS CORE$200,758
P01 · FY2008 · AG · contact PI
Statistical Designs and Methods for Partially Controlled HIV/AIDS Studies$360,891
R01 · FY2007 · DA · contact PI
DESIGN, RANDOMIZATION AND ANALYSIS CORE$103,275
P01 · FY2007 · AG · contact PI
DESIGN, RANDOMIZATION AND ANALYSIS CORE$64,262
P01 · FY2006 · AG · contact PI
Statistical Methods for Partially Controlled Studies$238,407
R01 · FY2005 · EY
Statistical Methods for Partially Controlled Studies$239,205
R01 · FY2004 · EY
Statistical Methods for Partially Controlled Studies$257,534
R01 · FY2002 · EY